One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Electromed logo
Electromed ELMD
$ 27.48 0.75%
report update icon

Quarterly report 2026-Q4
added 08-25-2026

Electromed Balance Sheet 2026-2010 | ELMD

Brief overview of Electromed's balance sheet strength

The comparison uses five available annual reports from the 2021–2025 interval.

The asset base progressed from $37.1 million to $53.8 million, equal to +45% overall and about 9.7% per year.

Liabilities grew faster than assets: +125.7% versus +45%. A substantial part of expansion was externally funded.

The equity ratio reached 80.3% from 87.4%. A high capital share reduces dependence on liabilities.

Cash accounts for 28.4% of assets versus 32% initially. The change indicates the degree of financial flexibility.

Retained earnings reached $21.2 million, changing +42% over the period. A positive accumulated result supports equity.

Conclusion

Taken together, the figures indicate acceptable resilience for Electromed. The next assessment depends on debt and equity trends.

Annual Balance Sheet Electromed

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Net Debt

- - - - - - -10.5 M -7.81 M -6.35 M -4.43 M -3.92 M -2.35 M -205 K 886 K -58.4 K -2.07 M -

Long Term Debt

- - - - - - - - - 1.1 M 1.16 M 1.2 M 1.25 M 1.33 M 1.39 M 1.58 M -

Long Term Debt Current

- - - - - - 72.3 K - 1.1 M 50.7 K 46.3 K 48.7 K 46.4 K 57.5 K 254 K - -

Total Non Current Liabilities

- - - - - - 8.87 K - - 1.1 M 1.16 M 1.2 M 1.25 M 1.44 M 1.67 M 1.75 M -

Total Current Liabilities

12.2 M 10.5 M 7.68 M 8.05 M 7.15 M 4.64 M 2.99 M 3.62 M 4.74 M 2.9 M 3.07 M 2.28 M 1.82 M 2.19 M 4.17 M - -

Total Liabilities

12.3 M 10.6 M 7.69 M 8.14 M 7.19 M 4.69 M 3 M 3.62 M 4.74 M 3.99 M 4.23 M 3.48 M 3.07 M 3.63 M 5.84 M 6.16 M -

Retained Earnings

28.6 M 21.2 M 23.7 M 18.8 M 15.8 M 14.9 M 13.7 M 9.52 M 6.86 M 4.96 M 2.73 M 515 K -578 K 711 K 2.04 M 1.85 M -

Total Assets

66.3 M 53.8 M 52.2 M 45.8 M 41.4 M 37.1 M 33.2 M 29.4 M 26.6 M 23.1 M 20.6 M 17.4 M 15.8 M 17.6 M 20.9 M 20.9 M -

Cash and Cash Equivalents

20.4 M 15.3 M 16.1 M 7.37 M 8.15 M 11.9 M 10.5 M 7.81 M 7.46 M 5.57 M 5.12 M 3.6 M 1.5 M 504 K 1.7 M 4.09 M 611 K

Book Value

54 M 43.2 M 44.5 M 37.7 M 34.2 M 32.4 M 30.2 M 25.7 M 21.9 M 19.1 M 16.4 M 13.9 M 12.7 M 13.9 M 15.1 M 14.7 M -

Total Shareholders Equity

54 M 43.2 M 44.5 M 37.7 M 34.2 M 32.4 M 30.2 M 25.7 M 22.6 M 19.1 M 16.4 M 13.9 M 12.7 M 13.9 M 15.1 M 14.7 M 7.46 M

All numbers in USD currency

Quarterly Balance Sheet Electromed

2026-Q4 2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.09 M 1.1 M 1.1 M 1.12 M 1.14 M 1.15 M 1.15 M 1.18 M 1.19 M 1.2 M 1.2 M 1.23 M 1.24 M 1.25 M 1.25 M 1.27 M 1.32 M 1.33 M 1.33 M 1.36 M 1.37 M 1.39 M 1.39 M 1.43 M 1.51 M 1.58 M 1.58 M

Total Liabilities

10.6 M 10.3 M 9.47 M 8.87 M 9.47 M 8.87 M 10.6 M 8.51 M 8.67 M 7.43 M 7.69 M 6.36 M 6.62 M 5.84 M 8.14 M 6.45 M 6.04 M 5.99 M 7.19 M 5.01 M 4.72 M 4.86 M 4.69 M 4.69 M 3.49 M 3.53 M 3 M 3 M 3.03 M 3.33 M 3.67 M 3.67 M - - 4.74 M 3.75 M 3.78 M 3.83 M 3.99 M 3.99 M 3.48 M 3.05 M 4.22 M 4.22 M 3.61 M 3.32 M 3.48 M 3.48 M 3.12 M 3.4 M 3.07 M 3.07 M 3.98 M 3.78 M 3.63 M 3.63 M 4.46 M 5.39 M 5.84 M 5.84 M 5.66 M 6.16 M 6.16 M 6.16 M

Retained Earnings

21.2 M 25.1 M 22.3 M 22.3 M 22.3 M 22.3 M 21.2 M 22.6 M 22.6 M 20.6 M 23.7 M 22.1 M 20.6 M 18.9 M 18.8 M 17.8 M 16.7 M 15.7 M 15.8 M 15.9 M 15.5 M 15.4 M 14.9 M 14.9 M 15.4 M 14.2 M 13.7 M 13.7 M 11.7 M 10.5 M 9.52 M 9.52 M 8.08 M 7.71 M 9.52 M 7.55 M 5.43 M 5.08 M 4.96 M 4.96 M 3.36 M 2.92 M 2.73 M 2.73 M 1.92 M 856 K 515 K 515 K 222 K -200 K -578 K -578 K 136 K 375 K 711 K 711 K 1.56 M 1.97 M 2.04 M 2.04 M 2.12 M 2.1 M 1.85 M 1.85 M

Total Assets

53.8 M 59.5 M 54.9 M 53.6 M 54.9 M 53.6 M 53.8 M 52.5 M 52.3 M 48.9 M 52.2 M 48.9 M 47 M 44.1 M 45.8 M 42.8 M 41.4 M 40.1 M 41.4 M 39 M 38.2 M 37.9 M 37.1 M 37.1 M 35.8 M 34.4 M 33.2 M 33.2 M 31.5 M 30.3 M 29.4 M 29.4 M 26.9 M 27.5 M 27.4 M 27.4 M 23.7 M 23.2 M 23.1 M 23.1 M 20.7 M 19.7 M 20.6 M 20.6 M 19 M 17.6 M 17.4 M 17.4 M 16.7 M 16.5 M 15.8 M 15.8 M 17.4 M 17.4 M 17.6 M 17.6 M 19.1 M 20.4 M 20.9 M 20.9 M 20.7 M 21.2 M 20.9 M 20.9 M

Cash and Cash Equivalents

15.3 M 17 M 13.8 M 14.1 M 13.8 M 14.1 M 15.3 M 15.2 M 16.2 M 13.9 M 16.1 M 11.7 M 10.4 M 7.02 M 7.37 M 6.78 M 6.91 M 6 M 8.15 M 9.84 M 10.5 M 11 M 11.9 M 11.9 M 11.7 M 11.1 M 10.5 M 11.1 M 9.21 M 8.03 M 9.21 M 8.03 M 7.21 M 7.75 M 7.21 M 7.75 M 6.84 M 5.79 M 6.84 M 5.79 M 4.82 M 3.82 M 4.82 M 3.82 M 4.53 M 3.78 M 3.6 M 2.9 M 2.45 M 2.28 M 1.5 M 2.28 M 1.24 M 1.08 M 1.24 M 1.08 M 1.01 M 1.48 M 1.01 M 1.48 M 1.75 M 2.95 M 1.75 M 2.95 M

Book Value

43.2 M 49.2 M 45.4 M 44.7 M 45.4 M 44.7 M 43.2 M 43.9 M 43.6 M 41.5 M 44.5 M 42.5 M 40.3 M 38.2 M 37.7 M 36.4 M 35.4 M 34.1 M 34.2 M 34 M 33.5 M 33 M 32.4 M 32.4 M 32.3 M 30.9 M 30.2 M 30.2 M 28.5 M 27 M 25.7 M 25.7 M 26.9 M 27.5 M 22.6 M 23.6 M 19.9 M 19.4 M 19.1 M 19.1 M 17.2 M 16.7 M 16.4 M 16.4 M 15.4 M 14.3 M 13.9 M 13.9 M 13.6 M 13.1 M 12.7 M 12.7 M 13.4 M 13.6 M 13.9 M 13.9 M 14.7 M 15.1 M 15.1 M 15.1 M 15.1 M 15 M 14.7 M 14.7 M

Total Shareholders Equity

44.5 M 49.2 M 45.4 M 44.7 M 45.4 M 44.7 M 43.2 M 43.9 M 43.6 M 41.5 M 44.5 M 42.5 M 40.3 M 38.2 M 37.7 M 36.4 M 35.4 M 34.1 M 34.2 M 34 M 33.5 M 33 M 32.4 M 33 M 32.9 M 32.3 M 32.3 M 30.9 M 28.5 M 28.5 M 28.5 M 27 M 23.8 M 23.8 M 23.8 M 23 M 20.7 M 20.1 M 19.9 M 19.4 M 17.2 M 16.7 M 16.4 M 16.4 M 15.4 M 14.3 M 13.9 M 13.9 M 13.6 M 13.1 M 12.7 M 12.7 M 13.4 M 13.6 M 13.9 M 13.9 M 14.7 M 15.1 M 15.1 M 15.1 M 15.1 M 15 M 14.7 M 14.7 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Electromed, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.78 1.14 % $ 72.4 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 94.23 1.33 % $ 121 B usaUSA
Myomo Myomo
MYO
$ 1.24 1.42 % $ 51.9 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
InspireMD InspireMD
NSPR
$ 0.47 1.71 % $ 30.2 M israelIsrael
Outset Medical Outset Medical
OM
$ 3.84 1.25 % $ 58.4 K usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.06 0.48 % $ 130 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 86.45 1.38 % $ 50.6 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 133.93 0.32 % $ 9.42 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.62 0.14 % $ 200 M canadaCanada
AVITA Medical AVITA Medical
RCEL
$ 13.1 0.07 % $ 365 M australiaAustralia
Sintx Technologies Sintx Technologies
SINT
$ 1.82 0.95 % $ 5.05 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 27.88 0.07 % $ 24.2 B britainBritain
Sensus Healthcare Sensus Healthcare
SRTS
$ 2.86 2.08 % $ 46.7 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 281.62 0.05 % $ 108 B usaUSA
Globus Medical Globus Medical
GMED
$ 76.31 0.01 % $ 10.3 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 22.41 0.45 % $ 513 M usaUSA
TELA Bio TELA Bio
TELA
$ 1.1 2.82 % $ 51.6 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 16.01 1.22 % $ 1.09 B usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 18.39 0.03 % $ 761 M usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 0.13 0.2 % $ 1.34 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 9.69 0.83 % $ 377 M usaUSA
Beyond Air Beyond Air
XAIR
$ 2.1 3.56 % $ 17.4 B usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.32 1.31 % $ 44.7 M usaUSA
PAVmed PAVmed
PAVM
$ 2.29 0.49 % $ 1.54 M usaUSA
Penumbra Penumbra
PEN
$ 320.12 0.03 % $ 12.5 B usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 91.77 0.37 % $ 18.2 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 43.0 0.01 % $ 63.7 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.38 0.5 % $ 611 M israelIsrael
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 14.72 2.02 % $ 527 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.51 0.25 % $ 33 M israelIsrael
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 22.25 1.46 % $ 522 M usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.7 0.21 % $ 695 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
- - $ 140 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA